AVGR News and Press, Avinger Inc.

$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 17, 2024 / Avinger, Inc. (NASDAQ:AVGR) , a commercial-stage medical device company developing and mar...

2024-06-14 09:24:30 ET More on Avinger Seeking Alpha’s Quant Rating on Avinger Historical earnings data for Avinger Financial information for Avinger Read the full article on Seeking Alpha For further details see: Avinger announces pricing ...

$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series Warrants REDWOOD CITY, CA / ACCESSWIRE / June 14, 2024 / Avinger, Inc. (NASDAQ:AVGR) , a commercial-stage medical device company developing and mar...

REDWOOD CITY, CA / ACCESSWIRE / June 5, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced that it will incre...

2024-05-24 17:34:50 ET More on Avinger Avinger, Inc. (AVGR) Q1 2024 Earnings Call Transcript Avinger, Inc. (AVGR) Q4 2023 Earnings Call Transcript Avinger enters partnership with Zylox-Tonbridge, to get $15 million of equity funding Seeking Alpha’s Qua...

REDWOOD CITY, CA / ACCESSWIRE / May 16, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of ...

2024-05-15 18:15:33 ET Avinger, Inc. (AVGR) Q1 2024 Earnings Call Transcript May 15, 2024, 04:30 PM ET Company Participants Matt Kreps - IR Jeff Soinski - CEO Nabeel Subainati - Principal Financial Officer Conference Call Participants Swayampakula Ram...

2024-05-15 16:18:09 ET More on Avinger Avinger, Inc. (AVGR) Q4 2023 Earnings Call Transcript Avinger enters partnership with Zylox-Tonbridge, to get $15 million of equity funding Seeking Alpha’s Quant Rating on Avinger Historical earnings data for Avin...

Advances New OCT-Guided Coronary Product Development REDWOOD CITY, CA / ACCESSWIRE / May 15, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatme...

Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...